The role of post-transplantation cyclosporine treatment in the course of cystic fibrosis pulmonary disease: A case report

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 4, 2012, Pages 714-716

  Tesse, Riccardina ^a   Manca, Antonio ^a   Abrusci, Maria Raffaella ^a   Pinto, Silvia ^a   Leonetti, Giuseppina ^a   De Robertis, Silvia ^a   Cavallo, Luciano ^a   De Robertis, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Bronchiectasis; Cyclosporine; Cystic fibrosis; Lung inflammation; Transplantation

Indexed keywords

CREATININE; CYCLOSPORIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ATELECTASIS; BODY MASS; BRONCHIECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LUNG CAPACITY; LUNG FUNCTION TEST; LUNG PARENCHYMA; LUNG PERFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; WEIGHT GAIN;

ADULT; CYCLOSPORINE; CYSTIC FIBROSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUNG; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 84863802656     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.653492     Document Type: Article

References (18)

1. Gibson, L.E., Cooke, R.E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959, 23, 545-549.
2. Kulczycki, L.L., Kostuch, M., Bellanti, J.A. A clinical perspective of cystic fibrosis and new genetic findings: Relationship of CFTR mutations to genotype-phenotype manifestations. Am J Med Genet A 2003, 116A, 262-267.
3. Brett, M.M., Simmonds, E.J., Ghoneim, A.T., Littlewood, J.M. The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch Dis Child 1992, 67, 1086-1088.
4. Lossos, I.S., Or, R., Goldstein, R.H., Conner, M.W., Breuer, R. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A. Exp Lung Res 1996, 22, 337-349.
5. FitzSimmons, S.C. The changing epidemiology of cystic fibrosis. J Pediatr 1993, 122, 1-9.
6. Tomashefski, H.F., Abramowsky, C.R., Dahms, B.B. (1993). The pathology of cystic fibrosis. In: Davis P, ed. Cystic fibrosis. New York: Marcel Dekker, 435-489.
7. Balough, K., McCubbin, M., Weinberger, M., Smits, W., Ahrens, R., Fick, R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995, 20, 63-70.
8. Khan, T.Z., Wagener, J.S., Bost, T., Martinez, J., Accurso, F.J., Riches, D.W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151, 1075-1082.
9. Cantin, A. Cystic fibrosis lung inflammation: Early, sustained, and severe. Am J Respir Crit Care Med 1995, 151, 939-941.
10. Armstrong, D.S., Grimwood, K., Carlin, J.B., Carzino, R., Gutièrrez, J.P., Hull, J., Olinsky, A., Phelan, E.M., Robertson, C.F., Phelan, P.D. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997, 156, 1197-1204.
11. Regamey, N., Tsartsali, L., Hilliard, T.N., Fuchs, O., Tan, H.L., Zhu, J., Qiu, Y.S., Alton, E.W., Jeffery, P.K., Bush, A., Davies, J.C. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2011. DOI: 10.1136/thoraxjnl-2011-200585.
12. Tan, H.L., Regamey, N., Brown, S., Bush, A., Lloyd, C.M., Davies, J.C. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011, 184, 252-258.
13. Klepac-Ceraj, V., Lemon, K.P., Martin, T.R., Allgaier, M., Kembel, S.W., Knapp, A.A., Lory, S., Brodie, E.L., Lynch, S.V., Bohannan, B.J., Green, J.L., Maurer, B.A., Kolter, R. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 2010, 12, 1293-1303.
14. Cystic Fibrosis Mutation Database. Available at http://www. genet.sickkids.on.ca/cftr/ Accessed on 15 July 2011.
15. Ravnik-Glavac, M., Atkinson, A., Glavac, D., Dean, M. DHPLC screening of cystic fibrosis gene mutations. Hum Mutat 2002, 19, 374-383.
16. Castaldo, G., Polizzi, A., Tomaiuolo, R., Cazeneuve, C., Girodon, E., Santostasi, T., Salvatore, D., Raia, V., Rigillo, N., Goossens, M., Salvatore, F. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann Hum Genet 2005, 69, 15-24.
17. Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., Nourse, J., Crabtree, G.R. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996, 80, S40-S45.
18. Shwachman, H., Kulczycki, L.L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child 1958, 96, 6-15.